Oxaliplatin, 5FU, leucovorin/Irinotecan , 5FU, leucovorin, Clinical Trials

1 actively recruiting trial

Also known as: mFOLFOX/mFOLFIRI

Pipeline

Phase 2: 1

Top Sponsors

Seoul National University Bundang Hospital1

Indications

Biliary Cancer Metastatic1
Cancer1

Other1 trial

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.